Retrospective cohort study links PPI use to drug-related problems in hospitalized renal disease patients.
Nearly half of hospitalized kidney patients had drug problems linked to stomach acid reducers
This retrospective cohort study evaluated 520 hospitalized internal nephrology inpatients to assess drug-related problems (DRPs) associated …
Nearly half of hospitalized kidney patients faced drug problems linked to stomach acid reducers. Other medicines and dialysis types also rai…
CZTL capsule therapy study design for acute ischemic stroke patients not eligible for IVT or with early deterioration
New Stroke Pill Could Help Patients Missed by Standard Care
This randomized, double-blind, placebo-controlled, multicenter clinical study design involved 1,208 eligible patients with acute ischemic st…
A large new study is testing if a specific herbal capsule can help stroke patients who miss out on standard treatments.
Pathophysiological review explores platelet activity and antiplatelet agents in metabolic dysfunction-associated steatohepatitis and steatotic liver disease.
New Role for Blood Cells in Fatty Liver Disease Could Change Treatment
This pathophysiological review examines the role of platelet activity and antiplatelet agents in metabolic dysfunction-associated steatohepa…
Understanding how blood cells affect your liver could lead to new, targeted treatments for a dangerous liver condition.